Evidence map›Paper›PMID 36325190›Full record

ArticleFrontiers in aging neuroscience2022

1,25-D3 attenuates cerebral ischemia injury by regulating mitochondrial metabolism

Yutian Li, Xiangling Li, Shuangli Xu, Yingzhe Zhao, Meng Pang, Xiaojun Zhang, Xuejian Wang, Yanqiang Wang

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yutian LiSchool of Pharmacy, Weifang Medical University, Weifang, China.
Xiangling LiDepartment of Internal Medicine, The Affiliated Hospital of Weifang Medical University, Weifang, China.
Shuangli XuEmergency Department, The Affiliated Hospital of Weifang Medical University, Weifang, China.
Yingzhe ZhaoDepartment of Neurology II, The Affiliated Hospital of Weifang Medical University, Weifang, China.
Meng PangDepartment of Neurology II, The Affiliated Hospital of Weifang Medical University, Weifang, China.
Xiaojun ZhangDepartment of Neurology II, The Affiliated Hospital of Weifang Medical University, Weifang, China.
Xuejian WangSchool of Pharmacy, Weifang Medical University, Weifang, China.
Yanqiang WangDepartment of Neurology II, The Affiliated Hospital of Weifang Medical University, Weifang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The brain injury caused by cerebral ischemia-reperfusion is related to mitochondrial damage. Maintaining the normal function of mitochondria, promoting angiogenesis, protecting neuronal cells, and resisting oxidative stress are the keys to functional recovery after acute ischemic stroke. In this study, we established a middle cerebral artery occlusion (MCAO) model and investigated the effects of 1α,25-dihydroxyvitamin D3 (VitD or 1,25-D3) on mitochondrial function

Indexed as

125-D3caspase-3cerebral ischemia-reperfusioncytochrome CMCAO/Rmitochondrial metabolismP53vitamin D receptor

Identifiers

PMID36325190
PMCPMC9618954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.